Lynch et al. (37) analyzed OncomineTM database to determine whether OGT was overexpressed in tumors, and found four microarray gene expression studies showing elevated OGT mRNA levels in human prostate carcinoma as compared to adjacent tissue samples. Here, OGT is linked to prostate carcinoma.